Skip to content

3CDN

Content Daily News

3CDN
  • News
  • Business
  • Entertainment
  • General
  • Health
  • Science
  • Sports
  • Technology

Cholesterol

Merck’s pill to reduce cholesterol on top of statins matches results from injectables - statnews.com

Merck’s Oral Cholesterol Pill, Enlicitide, Achieves 60% LDL Reduction, Matching Injectable Efficacy

Merck’s new oral cholesterol pill, enlicitide, achieved up to 60% LDL reduction in Phase 2 trials, matching injectable PCSK9 efficacy. Read the full analysis.
How a ‘one and done’ gene-editing treatment could lower cholesterol - The Washington Post

Gene Editing Offers Hope for a ‘One-and-Done’ Treatment to Permanently Lower Cholesterol

New gene-editing therapy shows significant, sustained reduction in high cholesterol risk factors after a single dose. Learn about the ‘one-and-done’ treatment and clinical trial results.
  • About Us
  • FAQ
  • Editorial Principles
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Sitemap
© 2025 3CDN Content Delivery News. All rights reserved.